Showing 13,301 - 13,320 results of 29,668 for search '(( 50 ((a decrease) OR (we decrease)) ) OR ( 5 ((step decrease) OR (nn decrease)) ))', query time: 0.73s Refine Results
  1. 13301

    VEGF reduces miR-30b expression in HUVECs. by Grant A. Howe (2558611)

    Published 2017
    “…<p>(A) RNA was isolated from HUVEC treated with 50ng/ml of VEGF for 24h and used to profile miRNA using Affymetrix gene expression arrays. …”
  2. 13302

    Vector genomes and GFP mRNA in heart and liver. by Bryan A. Piras (314201)

    Published 2013
    “…The shGFP group showed a 77% reduction in cardiac GFP mRNA compared to the shControl group (n=7/group, p<0.0001), and while the shGFP group showed a 39% decrease in mRNA in liver, the difference was not statistically significant (n=7/group, p=0.38).…”
  3. 13303

    Determination of the changes in contact area during osmotic stimulation of adhered primary hepatocytes. by Tabea A. Mundinger (124217)

    Published 2012
    “…The original relative contact area (i) changes considerably during hypoosmotic stimulation (ii) and does not return to its original area afterwards (iii). A rapid decrease in relative contact area can be observed after returning to normoosmotic media (iv) followed by the stabilization of the relative contact area (v). b) All areas defined as relative contact areas in the consensus of both wavelengths are represented here as black areas. …”
  4. 13304

    BMAL1 and PER1 protein and transcript levels are reduced by thyroxine treatment. by Jonathan A. Hardman (714625)

    Published 2015
    “…(b,d) PER1 protein was significantly decreased by T4 at 6, 12,18 and 24 hours. BMAL1 protein levels were also decreased significantly by T4 at time points 6,12 and 18 hours showing a tendency to decrease at 0 and 24 hours. …”
  5. 13305

    AXL overexpression dampens the response to IFNα. by Scott A. Read (788751)

    Published 2015
    “…<p>Stable transfection of Huh-7 cells with PCMV6-AXL was confirmed by western blot, using antibodies against AXL or the fusion Myc tag (A). Huh-7 cells overexpressing AXL induced a stronger but more transient phosphorylation of STAT1 (B), with increased phosphorylation at 15 and 30 minutes post-IFN (50 u/ml), but a strong decrease at 1 h (2 replicates). …”
  6. 13306

    Evaluation of MGMT inhibitors with chemosensor 1. by Andrew A. Beharry (1940068)

    Published 2016
    “…<p>Incubation of purified MGMT enzyme with the inhibitors BG and PaTrin-2 led to a concentration dependent decrease in observed final fluorescence intensity, indicative of MGMT inhibition. …”
  7. 13307

    RNA degrades with time. by Jeffrey A. Blair (3178230)

    Published 2016
    “…(C) An antibody to rRNA shows a similar decrease of immunoreactivity with time, (D) but an antibody to dsDNA remains robust even after a PMI of 46 h. …”
  8. 13308

    Therapeutic efficacy study in <i>E</i>. <i>granulosus</i> infected mice. by Julia A. Loos (737868)

    Published 2017
    “…<p>(A) Box plots showing the comparative distribution of the weight (g) of cysts recovered from untreated mice (C) and treated with albendazole (ABZ, 5 mg/kg/d), metformin (Met, 50 mg/kg/d) and the combination of both drugs (ABZ+Met) for 60 days. …”
  9. 13309

    DataSheet_1_Effectiveness and cost-effectiveness of human papillomavirus vaccination strategies among men who have sex with men in China: a modeling study.docx by Yuwei Li (1612018)

    Published 2023
    “…When the vaccine price decreased by 60%, the ICER was reduced to 7,344.44 USD/QALY (4,392.89-10,309.23), indicating good cost-effectiveness taking China’s per capita GDP as a threshold.…”
  10. 13310

    Table_1_A Label-Free Quantitative Proteomic Analysis of Mouse Neutrophil Extracellular Trap Formation Induced by Streptococcus suis or Phorbol Myristate Acetate (PMA).DOC by Xiaoping Wang (110673)

    Published 2018
    “…However, the signaling pathway by which S. suis induces NET formation remains to be elucidated. In the present study, we used a label-free quantitative proteomic analysis of mouse NET formation induced by S. suis or phorbol myristate acetate (PMA), a robust NET inducer. …”
  11. 13311

    Image_2_A Label-Free Quantitative Proteomic Analysis of Mouse Neutrophil Extracellular Trap Formation Induced by Streptococcus suis or Phorbol Myristate Acetate (PMA).PDF by Xiaoping Wang (110673)

    Published 2018
    “…However, the signaling pathway by which S. suis induces NET formation remains to be elucidated. In the present study, we used a label-free quantitative proteomic analysis of mouse NET formation induced by S. suis or phorbol myristate acetate (PMA), a robust NET inducer. …”
  12. 13312

    Image_1_A Label-Free Quantitative Proteomic Analysis of Mouse Neutrophil Extracellular Trap Formation Induced by Streptococcus suis or Phorbol Myristate Acetate (PMA).PDF by Xiaoping Wang (110673)

    Published 2018
    “…However, the signaling pathway by which S. suis induces NET formation remains to be elucidated. In the present study, we used a label-free quantitative proteomic analysis of mouse NET formation induced by S. suis or phorbol myristate acetate (PMA), a robust NET inducer. …”
  13. 13313
  14. 13314

    <i>Shank3</i> KO mice have disorganized ensembles for which correlations fail to enhance the transmission of information about social behavior. by Nicholas A. Frost (10739821)

    Published 2021
    “…The unimplanted cohort alone shows a similar significant decrease in interaction time for KO mice (165 +/− 15 seconds vs. 110 +/− 16 seconds for WT and KO respectively, <i>p</i> < 0.05, <i>t</i> test). …”
  15. 13315

    Table 5_Statin use during intensive care unit stay is associated with improved clinical outcomes in critically ill patients with sepsis: a cohort study.pdf by Caifeng Li (3912883)

    Published 2025
    “…Additionally, statin use was associated with decreased ICU mortality (odds ratio [OR], 0.43; 95% CI, 0.37-0.49; p < 0.001) and reduced in-hospital mortality (OR, 0.50; 95% CI, 0.45-0.57; p < 0.001). …”
  16. 13316

    Data_Sheet_1_Soil Microbial Composition and phoD Gene Abundance Are Sensitive to Phosphorus Level in a Long-Term Wheat-Maize Crop System.doc by Ming Lang (3757117)

    Published 2021
    “…In the present study in the North China Plain, we subjected the bacterial and fungal communities to amplicon sequencing analysis and characterized the alkaline phosphatase gene (phoD) encoding bacterial alkaline phosphatase in a long-term field experiment (10 years) with six mineral P fertilization rates up to 200 kg P ha<sup>–1</sup>. …”
  17. 13317

    Table 1_Statin use during intensive care unit stay is associated with improved clinical outcomes in critically ill patients with sepsis: a cohort study.docx by Caifeng Li (3912883)

    Published 2025
    “…Additionally, statin use was associated with decreased ICU mortality (odds ratio [OR], 0.43; 95% CI, 0.37-0.49; p < 0.001) and reduced in-hospital mortality (OR, 0.50; 95% CI, 0.45-0.57; p < 0.001). …”
  18. 13318

    Table 3_Statin use during intensive care unit stay is associated with improved clinical outcomes in critically ill patients with sepsis: a cohort study.docx by Caifeng Li (3912883)

    Published 2025
    “…Additionally, statin use was associated with decreased ICU mortality (odds ratio [OR], 0.43; 95% CI, 0.37-0.49; p < 0.001) and reduced in-hospital mortality (OR, 0.50; 95% CI, 0.45-0.57; p < 0.001). …”
  19. 13319

    Table 4_Statin use during intensive care unit stay is associated with improved clinical outcomes in critically ill patients with sepsis: a cohort study.pdf by Caifeng Li (3912883)

    Published 2025
    “…Additionally, statin use was associated with decreased ICU mortality (odds ratio [OR], 0.43; 95% CI, 0.37-0.49; p < 0.001) and reduced in-hospital mortality (OR, 0.50; 95% CI, 0.45-0.57; p < 0.001). …”
  20. 13320

    Table 2_Statin use during intensive care unit stay is associated with improved clinical outcomes in critically ill patients with sepsis: a cohort study.docx by Caifeng Li (3912883)

    Published 2025
    “…Additionally, statin use was associated with decreased ICU mortality (odds ratio [OR], 0.43; 95% CI, 0.37-0.49; p < 0.001) and reduced in-hospital mortality (OR, 0.50; 95% CI, 0.45-0.57; p < 0.001). …”